Description

KLOW is a four-peptide research formulation combining BPC-157, GHK-Cu, TB-500, and KPV into a single specialised blend. BPC-157 is researched in tissue response and cellular signalling studies, while GHK-Cu is investigated across cellular, skin biology, and collagen-related research. TB-500 is studied in relation to cellular migration and tissue-response pathways, while KPV adds another peptide component to the formulation for broader experimental investigation. The combination provides researchers with a defined multi-peptide material for studying complementary peptide activity and biological signalling. KLOW contains 10mg BPC-157, 50mg GHK-Cu, 10mg TB-500, and 10mg KPV, providing 80mg total across 10 vials.